ArticleJACC. Case reports2026
Recurrence of Prosthetic Aortic Valve Endocarditis After Percutaneous Mechanical Aspiration.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProsthetic valve endocarditis is a dreaded complication after transcatheter aortic valve replacement, especially in older patients with multiple comorbidities, who are poor surgical candidates. We describe a case of prosthetic aortic valve endocarditis in a patient who underwent percutaneous mechanical aspiration (PMA) and its sequelae over the following year. CASE SUMMARY: The patient presented with fever and chills after flu and respiratory syncytial virus vaccines and was found to have positive blood cultures for methicillin-resistant Staphylococcus aureus and bioprosthetic aortic valve endocarditis. He was a poor surgical candidate and underwent PMA with an AngioVac device with the development of a perivalvular abscess and pericardial effusion on subsequent admissions. DISCUSSION: PMA is increasingly being used for the treatment of endocarditis, especially right sided, but there is limited evidence on its use in left-sided endocarditis due to high risk of complications. TAKE-HOME MESSAGE: There is a high risk of complications with PMA in left-sided endocarditis, but it can be used as salvage therapy in poor surgical candidates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.